Restoration of Corneal Transparency by Mesenchymal Stem Cells
Sharad K Mittal, Masahiro Omoto, Afsaneh Amouzegar, Anuradha Sahu, Alexandra Rezazadeh, Kishore R Katikireddy, Dhvanit I Shah, Srikant K Sahu, Sunil K Chauhan, Sharad K Mittal, Masahiro Omoto, Afsaneh Amouzegar, Anuradha Sahu, Alexandra Rezazadeh, Kishore R Katikireddy, Dhvanit I Shah, Srikant K Sahu, Sunil K Chauhan
Abstract
Transparency of the cornea is indispensable for optimal vision. Ocular trauma is a leading cause of corneal opacity, leading to 25 million cases of blindness annually. Recently, mesenchymal stem cells (MSCs) have gained prominence due to their inflammation-suppressing and tissue repair functions. Here, we investigate the potential of MSCs to restore corneal transparency following ocular injury. Using an in vivo mouse model of ocular injury, we report that MSCs have the capacity to restore corneal transparency by secreting high levels of hepatocyte growth factor (HGF). Interestingly, our data also show that HGF alone can restore corneal transparency, an observation that has translational implications for the development of HGF-based therapy.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
- Abed E., Bouvard B., Martineau X., Jouzeau J.-Y., Reboul P., Lajeunesse D. Elevated hepatocyte growth factor levels in osteoarthritis osteoblasts contribute to their altered response to bone morphogenetic protein-2 and reduced mineralization capacity. Bone. 2015;75:111–119.
- Basu S., Hertsenberg A.J., Funderburgh M.L., Burrow M.K., Mann M.M., Du Y., Lathrop K.L., Syed-Picard F.N., Adams S.M., Birk D.E. Human limbal biopsy-derived stromal stem cells prevent corneal scarring. Sci. Transl. Med. 2014;6:266ra172.
- Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–317.
- Gendron R.L., Liu C.Y., Paradis H., Adams L.C., Kao W.W. MK/T-1, an immortalized fibroblast cell line derived using cultures of mouse corneal stroma. Mol. Vis. 2001;7:107–113.
- Hamil M.B. Mechanical injury. In: Krachmer J.H., Mannis M., Holland E.J., editors. Cornea. Mosby | Elsevier; 2011. pp. 1169–1185.
- Herrero-Fresneda I., Torras J., Franquesa M., Vidal A., Cruzado J.M., Lloberas N., Fillat C., Grinyó J.M. HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int. 2006;70:265–274.
- Hutcheon A.E.K., Sippel K.C., Zieske J.D. Examination of the restoration of epithelial barrier function following superficial keratectomy. Exp. Eye Res. 2007;84:32–38.
- Jester J.V. Corneal crystallins and the development of cellular transparency. Semin. Cell Dev. Biol. 2008;19:82–93.
- Jester J.V., Barry-Lane P.A., Petroll W.M., Olsen D.R., Cavanagh H.D. Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit. Cornea. 1997;16:177–187.
- Jester J.V., Brown D., Pappa A., Vasiliou V. Myofibroblast differentiation modulates keratocyte crystallin protein expression, concentration, and cellular light scattering. Invest. Ophthalmol. Vis. Sci. 2012;53:770–778.
- Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41–49.
- Lan Y., Kodati S., Lee H.S., Omoto M., Jin Y., Chauhan S.K. Kinetics and function of mesenchymal stem cells in corneal injury. Invest. Ophthalmol. Vis. Sci. 2012;53:3638–3644.
- Lee R.H., Yu J.M., Foskett A.M., Peltier G., Reneau J.C., Bazhanov N., Oh J.Y., Prockop D.J. TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo. Proc. Natl. Acad. Sci. USA. 2014;111:16766–16771.
- Ljubimov A.V., Saghizadeh M. Progress in corneal wound healing. Prog. Retin. Eye Res. 2015;49:17–45.
- Nishida T., Saika S. Cornea and sclera. In: Krachmer J.H., Mannis M., Holland E.J., editors. Cornea. Mosby | Elsevier; 2011. pp. 3–24.
- Omoto M., Katikireddy K.R., Rezazadeh A., Dohlman T.H., Chauhan S.K. Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation. Invest. Ophthalmol. Vis. Sci. 2014;55:6631–6638.
- Resnikoff S., Pascolini D., Mariotti S.P., Pokharel G.P. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull. World Health Organ. 2008;86:63–70.
- Torricelli A.A.M., Santhanam A., Wu J., Singh V., Wilson S.E. The corneal fibrosis response to epithelial-stromal injury. Exp. Eye Res. 2016;142:110–118.
- Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008;8:726–736.
- Wang J., Liao L., Tan J. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions. Expert Opin. Biol. Ther. 2011;11:893–909.
- Whitcher J.P., Srinivasan M., Upadhyay M.P. Corneal blindness: a global perspective. Bull. World Health Organ. 2001;79:214–221.
- Yi X., Li X., Zhou Y., Ren S., Wan W., Feng G., Jiang X. Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts. Int. J. Mol. Med. 2014;34:381–390.
Source: PubMed